Hostname: page-component-7b7567c8c-w7t8q Total loading time: 0 Render date: 2026-11-18T14:33:54.730Z Has data issue: false hasContentIssue false

Still living with mortality: the longevity risk transfer market after one decade

Published online by Cambridge University Press:  25 February 2019

Rights & Permissions [Opens in a new window]

Abstract

This paper updates Living with Mortality published in 2006. It describes how the longevity risk transfer market has developed over the intervening period, and, in particular, how insurance-based solutions – buy-outs, buy-ins and longevity insurance – have triumphed over capital markets solutions that were expected to dominate at the time. Some capital markets solutions – longevity-spread bonds, longevity swaps, q-forwards and tail-risk protection – have come to market, but the volume of business has been disappointingly low. The reason for this is that when market participants compare the index-based solutions of the capital markets with the customised solutions of insurance companies in terms of basis risk, credit risk, regulatory capital, collateral and liquidity, the former perform on balance less favourably despite a lower potential cost. We discuss the importance of stochastic mortality models for forecasting future longevity and examine some applications of these models, e.g. determining the longevity risk premium and estimating regulatory capital relief. The longevity risk transfer market is now beginning to recognise that there is insufficient capacity in the insurance and reinsurance industries to deal fully with demand and new solutions for attracting capital markets investors are now being examined – such as longevity-linked securities and reinsurance sidecars.

Information

Type
Sessional meetings: papers and abstracts of discussions
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© Institute and Faculty of Actuaries 2019
Figure 0

Figure 1Participants in the Longevity Risk Transfer MarketSource: Adapted from Loeys et al. (2007, Chart 10); PPF, Pension Protection Fund, PBGC, Pension Benefit Guaranty Corporation.

Figure 1

Figure 2A longevity swap involves the regular exchange of actual realised pension cash flows and pre-agreed fixed cash flowsSource: Coughlan (2007a).

Figure 2

Table 1Estimated Loss Probabilities for the Swiss Re Longevity-Spread Bond

Figure 3

Figure 3Fan chart of the projected LDIV showing the 98% confidence intervalSource: Hunt & Blake (2015, Figure 8).

Figure 4

Figure 4A q-forward exchanges fixed mortality for realised mortality at the maturity of the contractSource: Coughlan et al. (2007b, Figure 1)

Figure 5

Table 2An Illustrative Term Sheet for a Single q-forward to Hedge Longevity Risk

Figure 6

Table 3An Illustration of q-Forward Settlement for Various Outcomes of the Realised Reference Rate

Figure 7

Table 4Exposure Vector: Relative Weighting of Cohorts Over Time

Figure 8

Table 5Experience Ratio Matrix

Figure 9

Figure 5Mortality rates before, during and after the risk periodNote: Projected mortality rates are calculated using experience data available at end of the risk period.Source: Michaelson & Mulholland (2014, Exhibit 3).

Figure 10

Figure 6Distribution of the final index value and the potential for capital reductionSource: Michaelson & Mulholland (2014, Exhibit 4) – not drawn to scale.

Figure 11

Table 6Standardised Index Hedges Versus Customised Hedges

Figure 12

Figure 7Five-year mortality improvement correlations with England & Wales males aged 75Source: Coughlan et al. (2007c, Figure 9.6).

Figure 13

Figure 8The hedge effectiveness of q-forwardsSource: Coughlan (2007a).

Figure 14

Figure 9A genealogy of stochastic mortality modelsSource: Adapted from Cairns (2014)

Figure 15

Figure 10Longevity fan chart for 65-year-old English & Welsh malesSource: Own calculations.

Figure 16

Figure 11Cohort survivor fan chart for 65-year-old English & Welsh malesSource: Own calculations.

Figure 17

Figure 12Cohort mortality fan chart for 65-year-old English & Welsh malesSource: Own calculations.

Figure 18

Table 7UK Life Expectancy at Age 65

Figure 19

Figure 13Timeline into the futureNote: Structural modelling of medical-based mortality improvement explores the timing, magnitude and impact of different phases of new medical advances on the horizon.Source: RMS (2010) “Longevity Risk.”

Figure 20

Figure 14Cohort expected and forward mortality rate curves for a cohort currently aged 65 and q-forward maturity at age 75Note: Lines are illustrative only.Source: Adapted from Loeys et al. (2007, Chart 9).

Figure 21

Figure 15Expected and forward mortality rate curves for 65-year-old English & Welsh males, 2005–2025Note: Lines are illustrative only.Source: Adapted from Coughlan (2007a).

Figure 22

Figure 16Cumulative pension risk transfers by product and country, 2007–17Sources: LIMRA, Hymans Robertson, LCP and PFI analysis as of December 31, 2017.

Figure 23

Figure 17Cash flows under a LLS

Figure 24

Figure 18Typical sidecar structureSource: PFI.

Figure 25

Table A1UK Pension Buy-ins over £100 m, 2007–2016

Figure 26

Table A2UK Longevity Swaps, 2007–2017